Tenon Medical, Inc. ( TNON ) Q3 2025 Earnings Call November 13, 2025 4:30 PM EST Company Participants Steven Foster - CEO, President & Director Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners, Research Division Thomas McGovern Presentation Operator Greetings, and welcome to the Tenon Medical Third Quarter 2025 Financial Results and Corporate Update Conference Call. As a reminder, this call is being recorded.
Tenon Medical, Inc. (NASDAQ:TNON ) Q2 2025 Earnings Conference Call August 13, 2025 4:30 PM ET Company Participants Kevin Williamson - Chief Financial Officer Steven M. Foster - CEO, President & Director Conference Call Participants Nicholas Sherwood - Maxim Group LLC, Research Division Scott Robert Henry - Alliance Global Partners, Research Division Operator Greetings, and welcome to the Tenon, Inc. Second Quarter 2025 Earnings Conference Call.
Tenon Medical, Inc. (NASDAQ:TNON ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Steve Foster - President & Chief Executive Officer Kevin Williamson - Chief Financial Officer Conference Call Participants Scott Henry - Alliance Global Partners Nicholas Sherwood - Maxim Group Operator Greetings. And welcome to the Tenon Medical First Quarter 2025 Financial Results and Corporate Update Conference Call.
| Health Care Equipment & Supplies Industry | Healthcare Sector | Steven M. Foster CEO | NASDAQ (CM) Exchange | 88066N303 CUSIP |
| US Country | 27 Employees | - Last Dividend | 6 Sep 2024 Last Split | 27 Apr 2022 IPO Date |
Tenon Medical, Inc. is a notable medical device company with a focused mission to innovate in the field of surgical implant systems, specifically targeting the enhancement of sacroiliac joint fixation/fusion surgery outcomes. The company has been pioneering in this specialty since its establishment in 2012. Operating from its headquarters in Los Gatos, California, Tenon Medical has dedicated itself to addressing the unique challenges faced by surgeons and patients alike in sacroiliac joint surgeries. Through its commitment to advancing medical technology and improving surgical results, Tenon Medical has made significant strides in offering solutions that aim to reduce pain, improve mobility, and enhance the quality of life for patients suffering from sacroiliac joint dysfunctions.
This innovative product by Tenon Medical stands at the core of its offerings. It comprises a comprehensive set of instruments and implants specifically designed for the surgical preparation and fixation of the Sacroiliac Joint (SI-Joint) for fusion. The CATAMARAN SIJ Fusion System showcases the company's commitment to advancing surgical techniques and outcomes in sacroiliac joint fusion surgeries. The system is marketed in the United States and Puerto Rico, where it has been adopted by surgeons looking for reliable and effective solutions for SI-Joint dysfunctions. The focus on precision instruments and quality implants reflect Tenon Medical's dedication to excellence in medical device development.